Related Experiment Video
Updated: Mar 26, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
The Advantages and Disadvantages of Methods Used to Control Liver Bleeding: A Review
Saeed Nouri1, Mohammad Reza Sharif2, Hasan Afzali2
1Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
Context:
Despite advancements in the science of surgery, minimizing bleeding from parenchymal tissue of the liver continues to be one of the challenges surgeons are facing to protect patients' lives. However, the number of surgeries needing incisions in the liver tissue, e.g. metastatectomy, is constantly increasing.
Evidence Acquisition:
A MEDLINE and conventional search of the past 50 years of the medical literature was performed to identify relevant articles on hemostasis in the liver parenchymal tissue.
Results:
The studies that have been published on hemostasis in the liver parenchymal tissue can be classified into 3 categories: 1. surgical procedures; 2. methods affecting body hemodynamic; 3. pharmacological methods. The purpose of these studies are to identify the best therapeutic approaches that not only minimize the bleeding, but also save the maximum amount of the liver tissue and minimize the use of partial liver resections.
Conclusions:
The excessive blood loss and the long time needed to control the bleeding during liver surgery impose several side effects and complications on patients. Topical hemostatic agents such as ferric chloride, potassium aluminum sulfate (alum) and aluminum chloride are safely applicable in patients. These agents might be used along with other current methods to minimize the blood loss and the need for blood products during liver surgeries.
More Related Videos
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

